ES2193192T3 - Receptores de interleuquina-15. - Google Patents

Receptores de interleuquina-15.

Info

Publication number
ES2193192T3
ES2193192T3 ES95918389T ES95918389T ES2193192T3 ES 2193192 T3 ES2193192 T3 ES 2193192T3 ES 95918389 T ES95918389 T ES 95918389T ES 95918389 T ES95918389 T ES 95918389T ES 2193192 T3 ES2193192 T3 ES 2193192T3
Authority
ES
Spain
Prior art keywords
interleuquine
receivers
il15r
adns
recombinating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95918389T
Other languages
English (en)
Inventor
Dirk M Anderson
Judith G Giri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ES2193192T3 publication Critical patent/ES2193192T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE DESCRIBEN PROTEINAS DEL RECEPTOR DE LA INTERLEUQUINA-15 (IL15R), ADNS Y VECTORES DE EXPRESION QUE CODIFICAN LA IL-15R, Y PROCESOS PARA LA PRODUCCION DE IL-15R COMO PRODUCTOS DE CULTIVOS DE CELULAS RECOMBINANTES.
ES95918389T 1994-05-06 1995-05-04 Receptores de interleuquina-15. Expired - Lifetime ES2193192T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23691994A 1994-05-06 1994-05-06
US08/300,903 US5591630A (en) 1994-05-06 1994-09-06 Monoclonal antibodies that bind interleukin-15 receptors

Publications (1)

Publication Number Publication Date
ES2193192T3 true ES2193192T3 (es) 2003-11-01

Family

ID=26930223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95918389T Expired - Lifetime ES2193192T3 (es) 1994-05-06 1995-05-04 Receptores de interleuquina-15.

Country Status (11)

Country Link
US (1) US5591630A (es)
EP (1) EP0759942B1 (es)
AT (1) ATE233788T1 (es)
AU (1) AU695798B2 (es)
CA (1) CA2188279C (es)
DE (1) DE69529822T2 (es)
DK (1) DK0759942T3 (es)
ES (1) ES2193192T3 (es)
NZ (1) NZ285292A (es)
PT (1) PT759942E (es)
WO (1) WO1995030695A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548065B1 (en) * 1994-05-06 2003-04-15 Immunex Corporation Interleukin-15 receptors
US5795966A (en) * 1995-02-22 1998-08-18 Immunex Corp Antagonists of interleukin-15
DK0932417T3 (da) * 1996-10-17 2003-04-14 Immunomedics Inc Non-antigent toxinkonjugat og fusionsprotein af internaliserende receptorsystem
ATE229342T1 (de) * 1997-02-21 2002-12-15 Vlaams Interuniv Inst Biotech Verwendung von interleukin-15
JP2002519439A (ja) * 1998-07-07 2002-07-02 久光製薬株式会社 Ｉｌ−１５に標的されたアンチセンスオリゴヌクレオチド
CA2401979A1 (en) * 2000-03-03 2001-09-13 University Of Utah Research Foundation Mass1 gene, a target for anticonvulsant drug development
US7329405B2 (en) * 2001-08-23 2008-02-12 Genmab A/S Human antibodies specific for interleukin 15 (IL-15)
US7247304B2 (en) * 2001-08-23 2007-07-24 Genmab A/S Methods of treating using anti-IL-15 antibodies
RS51829B (sr) * 2001-08-23 2012-02-29 Genmab A/S. Ljudska antitela specifična za interleukin 15 (il-15)
EP3263581B2 (en) 2005-05-17 2025-07-09 University of Connecticut Compositions and methods for immunomodulation in an organism
EP1777294A1 (en) 2005-10-20 2007-04-25 Institut National De La Sante Et De La Recherche Medicale (Inserm) IL-15Ralpha sushi domain as a selective and potent enhancer of IL-15 action through IL-15Rbeta/gamma, and hyperagonist (IL15Ralpha sushi -IL15) fusion proteins
NZ569541A (en) 2006-01-13 2012-05-25 Us Gov Health & Human Serv Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells
NZ599338A (en) 2007-06-27 2013-11-29 Marinepolymer Tech Inc Complexes of il-15 and il-15ralpha and uses thereof
ES2598005T3 (es) 2009-08-14 2017-01-24 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Uso de IL-15 para aumentar la salida del timo y para tratar la linfopenia
WO2011031986A1 (en) 2009-09-10 2011-03-17 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Office Of Technology Transfer, National Institutes Of Health Assays for soluble il-15 receptor alpha
US20150359853A1 (en) 2012-10-24 2015-12-17 Admune Therapeutics Llc Il-15r alpha forms, cells expressing il-15r alpha forms, and therapeutic uses of il-15r alpha and il-15/il-15r alpha complexes
US11401312B2 (en) 2013-04-19 2022-08-02 Cytune Pharma Cytokine derived treatment with reduced vascular leak syndrome
ES2811974T3 (es) 2014-07-29 2021-03-15 Novartis Ag Regímenes de aumento escalonado de la dosis del heterodímero de il-15 e il-15ralfa para tratar afecciones
CN109715196A (zh) 2016-06-13 2019-05-03 转矩医疗股份有限公司 用于促进免疫细胞功能的组合物和方法
CA3074826A1 (en) 2017-09-05 2019-03-14 Torque Therapeutics, Inc. Therapeutic protein compositions and methods of making and using the same
CN112795543B (zh) * 2021-02-04 2022-09-27 华中农业大学 杂交瘤细胞株及其分泌的抗草鱼IL-15Rα单克隆抗体和应用
US20260048099A1 (en) 2022-08-16 2026-02-19 The United States Of America, As Represented By The Secretary, Deparment Of Health And Human Service Synergistic interactions for improved cancer treatment

Also Published As

Publication number Publication date
WO1995030695A1 (en) 1995-11-16
AU2434495A (en) 1995-11-29
ATE233788T1 (de) 2003-03-15
DE69529822T2 (de) 2003-12-11
AU695798B2 (en) 1998-08-20
NZ285292A (en) 1998-08-26
DE69529822D1 (de) 2003-04-10
CA2188279A1 (en) 1995-11-16
PT759942E (pt) 2003-07-31
EP0759942A4 (en) 1999-05-12
US5591630A (en) 1997-01-07
CA2188279C (en) 2010-01-26
DK0759942T3 (da) 2003-06-10
EP0759942B1 (en) 2003-03-05
EP0759942A1 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
ES2193192T3 (es) Receptores de interleuquina-15.
ES2145451T3 (es) Secuencia de dna y proteina de cancer de mamas codificada especifica para mamas.
DE69739366D1 (de) Aktive und inactive CC-Chemokinrezeptoren und Nukleinsäuremoleküle, die für diesen Rezeptor kodieren
DE69426033D1 (de) Für die alpha-1e untereinheit des menschlichen kalziumkanals kodierende dna
NO900770D0 (no) Produksjon av glykoseoksidase i rekombinante systemer.
ID23374A (id) Halogenopirimidin
MX9700789A (es) Composicion curativa bioadhesiva para heridas.
ES8704546A1 (es) Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano
FI963070A0 (fi) Klooripyrimidiinivälituotteita
DE3586697D1 (en) Aktive thymopentin-analoga.
ES2125864T3 (es) Vectores bacterianos.
DE69413039D1 (de) Prostaglandin rezeptor fp und kodierende dns
DE69432470D1 (de) Dna kodierend für prostaglandin rezeptor ip
ES2191011T3 (es) Acido nucleico, vector de expresion y composiciones para la identificacion y sintesis de sialiltransferasas recombinantes.
DK0952853T3 (da) Konjugat omfattende et aktivt middel, et polypeptid og en polyether
TR199802512T2 (xx) Plastik par�alar�n asamblaj�n�n y�ksek h�zda asamblaj� i�in proses.
ES2048142T3 (es) Procedimiento de obtencion de polidesoxirribonucleotidos sustancialmente puros y no informacionales que tienen actividades biologicas, y producto respectivo.
ES2061787T3 (es) Combinacion de inhibidores de la enzima de conversion de la angiotensina con moduladores del canal del potasio, asi como su empleo en medicamentos.
DE69120390D1 (de) Kollagen-bindendes protein sowie dessen herstellung
ES2126575T3 (es) Sacarosa-fosfato-sintasa (sps), su procedimiento de preparacion, su adnc, y utilizacion de adnc para modificar la expresion de sps en celulas vegetales.
MX9307007A (es) Vectores de expresion para tripsina y tripsinogeno de bovino y celulashuesped transformadoras con los mismos.
HUT41002A (en) Process for preparing anticonvulsives
ES2183515T3 (es) Peptidomimeticos de azol utilizados como antagonistas del receptor de la trombina.
PT931082E (pt) Derivados de acido nodulisporico
ES2136199T3 (es) Expresion multicistronica de genes recombinantes en celulas bacterianas.